Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

van Nagell JR Jr, Burgess BT, Miller RW, Baldwin L, DeSimone CP, Ueland FR, Huang B, Chen Q, Kryscio RJ, Pavlik EJ.

Obstet Gynecol. 2018 Nov;132(5):1091-1100. doi: 10.1097/AOG.0000000000002921.

PMID:
30303916
2.

Population-Based Analysis of Patient Age and Other Disparities in the Treatment of Ovarian Cancer in Central Appalachia and Kentucky.

Ore RM, Chen Q, DeSimone CP, Miller RW, Baldwin LA, van Nagell JR Jr, Huang B, Tucker TC, Johnson MS, Fredericks TI, Ueland FR.

South Med J. 2018 Jun;111(6):333-341. doi: 10.14423/SMJ.0000000000000821.

PMID:
29863220
3.

Symptoms Relevant to Surveillance for Ovarian Cancer.

Ore RM, Baldwin L, Woolum D, Elliott E, Wijers C, Chen CY, Miller RW, DeSimone CP, Ueland FR, Kryscio RJ, Nagell JR, Pavlik EJ.

Diagnostics (Basel). 2017 Mar 20;7(1). pii: E18. doi: 10.3390/diagnostics7010018.

4.

Complications from Surgeries Related to Ovarian Cancer Screening.

Baldwin LA, Pavlik EJ, Ueland E, Brown HE, Ladd KM, Huang B, DeSimone CP, van Nagell JR, Ueland FR, Miller RW.

Diagnostics (Basel). 2017 Mar 8;7(1). pii: E16. doi: 10.3390/diagnostics7010016.

5.

Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.

Lefringhouse JR, Neward E, Ueland FR, Baldwin LA, Miller RW, DeSimone CP, Kryscio RJ, van Nagell JR, Pavlik EJ.

Womens Health (Lond). 2016 Jun;12(3):303-11. doi: 10.2217/whe.15.111. Epub 2016 May 18.

6.

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.

Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR Jr, Ueland FR.

Gynecol Oncol. 2014 Oct;135(1):8-12. doi: 10.1016/j.ygyno.2014.07.091. Epub 2014 Jul 25.

PMID:
25068975
7.

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.

Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7. doi: 10.1097/AOG.0b013e318298def5.

PMID:
23969786
8.

Ten-year relative survival for epithelial ovarian cancer.

Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG.

Obstet Gynecol. 2012 Sep;120(3):612-8.

PMID:
22914471
9.

Bilateral ovarian steroid cell tumours and massive macronodular adrenocortical disease in a patient with hereditary leiomyomatosis and renal cell cancer syndrome.

Arora R, Eble JN, Pierce HH, Crispen PL, DeSimone CP, Lee EY, Karabakhtsian RG.

Pathology. 2012 Jun;44(4):360-3. doi: 10.1097/PAT.0b013e328353bf5a. No abstract available.

PMID:
22565324
10.

Small cell carcinoma of the ovary of hypercalcemic type: a case report.

McDonald JM, Karabakhtsian RG, Pierce HH, Iocono JA, Desimone CP, Bayliff SL, Ueland FR.

J Pediatr Surg. 2012 Mar;47(3):588-92. doi: 10.1016/j.jpedsurg.2011.12.004.

PMID:
22424359
11.

Selective inguinal lymphadenectomy in the treatment of invasive squamous cell carcinoma of the vulva.

Desimone CP, Elder J, van Nagell JR Jr.

Int J Surg Oncol. 2011;2011:284374. doi: 10.1155/2011/284374. Epub 2011 Jun 9.

12.

Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening.

van Nagell JR Jr, Miller RW, DeSimone CP, Ueland FR, Podzielinski I, Goodrich ST, Elder JW, Huang B, Kryscio RJ, Pavlik EJ.

Obstet Gynecol. 2011 Dec;118(6):1212-21. doi: 10.1097/AOG.0b013e318238d030.

PMID:
22105249
13.
14.

Cervical cancer survival for patients referred to a tertiary care center in Kentucky.

Seamon LG, Tarrant RL, Fleming ST, Vanderpool RC, Pachtman S, Podzielinski I, Branscum AJ, Feddock JM, Randall ME, Desimone CP.

Gynecol Oncol. 2011 Dec;123(3):565-70. doi: 10.1016/j.ygyno.2011.09.008. Epub 2011 Oct 2.

PMID:
21963092
15.

Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.

Ueland FR, Desimone CP, Seamon LG, Miller RA, Goodrich S, Podzielinski I, Sokoll L, Smith A, van Nagell JR Jr, Zhang Z.

Obstet Gynecol. 2011 Jun;117(6):1289-97. doi: 10.1097/AOG.0b013e31821b5118.

PMID:
21606739
16.

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.

Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell JR Jr, Zhang Z, Ueland FR.

Obstet Gynecol. 2011 Jun;117(6):1298-306. doi: 10.1097/AOG.0b013e31821b1d80.

PMID:
21555961
17.

Cervical stromal invasion predicting survival in endometrial cancer.

Ferriss JS, Brix W, Tambouret R, DeSimone CP, Stoler M, Modesitt SC.

Obstet Gynecol. 2010 Nov;116(5):1035-41. doi: 10.1097/AOG.0b013e3181f73fc2.

PMID:
20966686
18.

Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.

Saunders BA, Podzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, Seamon L, Ubellacker J, Pavlik EJ, Kryscio RJ, van Nagell JR Jr.

Gynecol Oncol. 2010 Sep;118(3):278-82. doi: 10.1016/j.ygyno.2010.05.013. Epub 2010 Jun 15.

PMID:
20554314
19.

Predicting risk of malignancy in adnexal masses.

McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2010 Apr;115(4):687-94. doi: 10.1097/AOG.0b013e3181d44053.

PMID:
20308826
20.

Suberoylanilide hydroxamic acid (SAHA) potentiates paclitaxel-induced apoptosis in ovarian cancer cell lines.

Dietrich CS 3rd, Greenberg VL, DeSimone CP, Modesitt SC, van Nagell JR, Craven R, Zimmer SG.

Gynecol Oncol. 2010 Jan;116(1):126-30. doi: 10.1016/j.ygyno.2009.09.039. Epub 2009 Oct 28.

PMID:
19875160

Supplemental Content

Loading ...
Support Center